Mcgirr David W J
SEC-identified person · CIK 1219023 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Rhythm Pharmaceuticals, INC. SRYTM | Director | filed 2017 - 2026 |
| Insmed Inc INSM | Director | filed 2013 - 2026 |
| X4 Pharmaceuticals, Inc XFOR | Director | filed 2017 - 2025 |
| Vyne Therapeutics Inc. VYNE | Director | filed 2018 - 2019 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014 - 2017 |
| Relypsa Inc RLYP | Director | filed 2013 - 2016 |
| Cubist Pharmaceuticals INC cbst | SVP & Chief Financial Officer | filed 2006 - 2013 |
| Lifecell Corp LIFC | Director | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.